Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | GLA | P06280 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18814886 | 0.84 | ALDH1A1 (0.50) | ALDH1A1GLATSHRTP53MEN1 | |
| SCHEMBL21301180 | 0.80 | ALDH1A1 (0.46) | ALDH1A1GLATSHRTP53MEN1 | |
| SCHEMBL10591288 | 0.79 | CYP3A4 (0.64) | ALDH1A1GLATSHRTP53CYP3A4 | |
| SCHEMBL23652017 | 0.77 | MEN1 (0.34) | ALDH1A1GLATSHRCYP3A4LMNA | |
| SCHEMBL20172629 | 0.76 | FAAH (0.42) | ALDH1A1LMNAMEN1KMT2AL3MBTL1 | |
| SCHEMBL2557200 | 0.75 | ALDH1A1 (0.61) | ALDH1A1GLATSHRTP53CYP3A4 | |
| SCHEMBL11142657 | 0.75 | ALDH1A1 (0.61) | ALDH1A1GLATSHRTP53CYP3A4 | |
| Water SCHEMBL16335551 | 0.73 | ALDH1A1 (0.59) | ALDH1A1GLATSHRTP53CYP3A4 | |
| SCHEMBL21204252 | 0.73 | ALDH1A1 (0.59) | ALDH1A1GLATSHRTP53CYP3A4 | |
| SCHEMBL22163727 | 0.73 | MEN1 (0.32) | MEN1KMT2ATRPM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210159416-A1 | LIGHT EMITTING DEVICE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-05-27 | — | — | US | disclosed |
| US-20210061794-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-03-04 | — | — | US | disclosed |
| US-10038146-B2 | Organic light-emitting compound and organic electroluminescent device using same | DOOSAN CORPORATION (KR) | 2018-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10038146-B2 | Organic light-emitting compound and organic electroluminescent device using same | IDO1, IDO2, KYNU | ALDH1A1 458/4885GLA 786/4885TSHR 3344/4885 |
| US-20210061794-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, TERT, TELO2 | ALDH1A1 20/4885GLA 44/4885TSHR 4547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.